AA
KDNY

AlphaCentric Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

AlphaCentric Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,500
Closed -$40K – 225
2020
Q4 		$40K Buy
+2,500
New +$40K 0.02% 191